A national pharmacare plan for Canadians holds as many unanswered questions now as it did before the federal election wi
McKesson Canada President Paula Keays is appealing to the pharmaceutical and medical industry to improve accessibility t
Rising drug costs are plaguing public and private health insurance plans alike. In response to this trend, British Colum
A new report by the Patented Medicine Prices Review Board (PMPRB) reveals that prescription drug expenditures by Canadia
The federal government announced today the final amendments to the Patented Medicines Regulations which it says will red
The Advisory Council on the Implementation of National Pharmacare announced today that it is recommending that Canada im
Evolve Funds Group has launched an exchange-traded fund focused on the marijuana industry in the United States.